## Abstract About 170 million Chinese are infected chronically with HBV and 10% suffer from chronic hepatitis. Around half a million Chinese die from hepatitis B caused hepatocellular carcinoma and endstage cirrhosis each year. From 1983 to the present, a controlled clinical trial involving 80,000
Management of hepatitis B in China
β Scribed by Guang Bi Yao
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 185 KB
- Volume
- 61
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Sera from 20 Chinese patients with chronic hepatitis B were examined for hepatitis B e antigen and hepatitis B virus (HBV) DNA. There was considerable discordance with HBV DNA not being detectable in 10 out of 13 (77%) patients who were hepatitis B e antigen positive. Further testing fo
Hospitals in China, as in many parts of the world, are facing unprecedented changes. The situation in China may be more complicated than in some countries, because these changes are compounded by the inΒ―uence of major changes in the macro-economic system as well. In response to this situation the Ch
## Abstract In this paper the focus is on marketβwide credit protection. More exactly, the newly introduced __iTraxx Greater China__ credit default swap (CDS) index is examined, and to what degree this index can be used to protect against marketβwide credit risk in the Greater China area is assesse
Key Points 1. Hepatitis B virus replication is associated with a severe outcome in patients with decompensated cirrhosis. 2. Viral suppression induced by antivirals results in a clinical improvement that allows liver transplantation to be delayed or avoided. 3. Early treatment intervention is mandat